Most-read Wikipedia articles: French holly, Vietnamese sex positions and Japanese pornstars

A glimpse into national psyches.

Via Chris Applegate on Twitter, here's a list of the most viewed articles on each of the 35 most active versions of Wikipedia in 2012.

It's a curious collection of pieces: some boring, some weird, and most just vain. Let's look at the fun stuff first.

The weird

Japanese: AV女優一覧, a list of lists of "adult video" actresses. No English language version of this one, despite my, ahem, exhaustive research. I particularly like that it's not even a list of porn actresses; it's a list of lists of porn actresses.

Vietnamese: Danh sách tư thế quan hệ tình dục/Sex position. Because how else will you learn about sex positions?

German: Sackgasse/Cul-de-sac. I don't know why cul-de-sacs are such a source of curiosity for German-speakers. But they are.

French: Houx crénelé/Ilex crenata. French-speakers apparently care deeply about an ornamental species of holly native to east Asia.

The boring

Some countries use Wikipedia to look up normal boring things. How unimaginative of them.

Croatian: Zakon o sprječavanju internetskog piratstva/Stop Online Piracy Act

Slovak: Majstrovstvá sveta v ľadovom hokeji 2012/2012 IIHF World Championship

Czech: Seznam historických výročí/List of historical anniversaries

Danish: Te/Tea

Norwegian: Schrøder, an article about the Norwegian surname

Dutch: Hua Shan/Mount Hua

Turkish: Mustafa Kemal Atatürk/Mustafa Kemal Atatürk

Thai: สมาคมประชาชาติแห่งเอเชียตะวันออกเฉียงใต้/Association of Southeast Asian Nations

Italian: Grey's Anatomy/Grey's Anatomy

Catalan: Mario Conde, a Spanish banker.

Hungarian: Magyar névnapok betűrendben, a list of Hungarian "name days".

Tech companies seem to be especially popular, and one in particular:

Chinese: 百度/Baidu

Korean: 네이버/Naver

Indonesian: Facebook/Facebook

Spanish: Facebook/Facebook

English: Facebook

The vain

Do you know what Wikipedians really like to do? Look up their own country:

Slovene: Slovenija/Slovenia

Estonian: Eesti/Estonia

Lithuanian: Lietuva/Lithuania

Greek: Ελλάδα/Greece

Hebrew: ישראל/Israel

Romanian: România/Romania

Finnish: Suomi/Finland

Swedish: Sverige/Sweden

Polish: Polska/Poland

Russian: Россия/Russia

Bulgarian: България/Bulgaria

Ukrainian: Україна/Ukraine

And a couple of not-quite entries:

Portugese: Brasil/Brazil

Persian: تهران/Tehran

Arabic: مصر/Egypt

Photograph: Getty Images

Alex Hern is a technology reporter for the Guardian. He was formerly staff writer at the New Statesman. You should follow Alex on Twitter.

Getty Images/ Staff
Show Hide image

The answer to the antibiotics crisis might be inside your nose

The medical weapons we have equipped ourselves with are losing their power. But scientists scent an answer. 

They say there’s a hero in everyone. It turns out that actually, it resides within only about ten percent of us. Staphylococcus lugdunensis may be the species of bacteria that we arguably don’t deserve, but it is the one that we need.

Recently, experts have cautioned that we may be on the cusp of a post-antibiotic era. In fact, less than a month ago, the US Centres for Disease Control and Prevention released a report on a woman who died from a "pan-resistant" disease – one that survived the use of all available antibiotics. Back in 1945, the discoverer of penicillin, Alexander Fleming, warned during his Nobel Prize acceptance speech against the misuse of antibiotics. More recently, Britain's Chief Medical Officer Professor Dame Sally Davies has referred to anti-microbial resistance as “the greatest future threat to our civilisation”.

However, hope has appeared in the form of "lugdunin", a compound secreted by a species of bacteria found in a rather unlikely location – the human nose.

Governments and health campaigners alike may be assisted by a discovery by researchers at the University of Tubingen in Germany. According to a study published in Nature, the researchers had been studying Staphylococcus aureus. This is the bacteria which is responsible for so-called "superbug": MRSA. A strain of MRSA bacteria is not particularly virulent, but crucially, it is not susceptible to common antibiotics. This means that MRSA spreads quickly from crowded locations where residents have weaker immune systems, such as hospitals, before becoming endemic in the wider local community. In the UK, MRSA is a factor in hundreds of deaths a year. 

The researchers in question were investigating why S. aureus is not present in the noses of some people. They discovered that another bacteria, S. lugdunensis, was especially effective at wiping out its opposition, even MRSA. The researchers named the compound created and released by the S. lugdunensis "lugdunin".

In the animal testing stage, the researchers observed that the presence of lugdunin was successful in radically reducing and sometimes purging the infection. The researchers subsequently collected nasal swabs from 187 hospital patients, and found S. aureus on roughly a third of the swabs, and S. lugdunensis on up to 10 per cent of them. In accordance with previous results, samples that contained both species saw an 80 per cent decrease of the S. aureus population, in comparison to those without lugdunin.

Most notably, the in vitro (laboratory) testing phase provided evidence that the new discovery is also useful in eliminating other kinds of superbugs, none of which seemed to develop resistance to the new compound. The authors of the study hypothesised that lugdunin had evolved  “for the purpose of bacterial elimination in the human organism, implying that it is optimised for efficacy and tolerance at its physiological site of action". How it works, though, is not fully understood. 

The discovery of lugdunin as a potential new treatment is a breakthrough on its own. But that is not the end of the story. It holds implications for “a new concept of finding antibiotics”, according to Andreas Peschel, one of the bacteriologists behind the discovery.

The development of antibiotics has drastically slowed in recent years. In the last 50 years, only two new classes of this category of medication have been released to the market. This is due to the fact almost all antibiotics in use are derived from soil bacteria. By contrast, the new findings record the first occurrence of a strain of bacteria that exists within human bodies. Some researchers now suggest that the more hostile the environment to bacterial growth, the more likely it may be for novel antibiotics to be found. This could open up a new list of potential areas in which antibiotic research may be carried out.

When it comes to beating MRSA, there is hope that lugdunin will be our next great weapon. Peschel and his fellow collaborators are in talks with various companies about developing a medical treatment that uses lugdunin.

Meanwhile, in September 2016, the United Nations committed itself to opposing the spread of antibiotic resistance. Of the many points to which the UN signatories have agreed, possibly the most significant is their commitment to “encourage innovative ways to develop new antibiotics”. 

The initiative has the scope to achieve a lot, or dissolve into box ticking exercise. The discovery of lugdunin may well be the spark that drives it forward. Nothing to sniff about that. 

Anjuli R. K. Shere is a 2016/17 Wellcome Scholar and science intern at the New Statesman